Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$2.24 - $2.66 $347,831 - $413,050
-155,282 Reduced 26.47%
431,406 $1.15 Million
Q4 2023

Feb 13, 2024

SELL
$1.07 - $2.5 $165,488 - $386,655
-154,662 Reduced 20.86%
586,688 $1.39 Million
Q3 2023

Nov 13, 2023

BUY
$1.38 - $3.31 $25,320 - $60,731
18,348 Added 2.54%
741,350 $1.04 Million
Q2 2023

Aug 11, 2023

SELL
$2.33 - $6.84 $3.62 Million - $10.6 Million
-1,554,107 Reduced 68.25%
723,002 $2.19 Million
Q1 2023

May 12, 2023

SELL
$3.46 - $7.98 $203,133 - $468,497
-58,709 Reduced 2.51%
2,277,109 $14.2 Million
Q4 2022

Feb 13, 2023

BUY
$5.26 - $12.19 $310,350 - $719,234
59,002 Added 2.59%
2,335,818 $14.2 Million
Q3 2022

Nov 14, 2022

SELL
$9.86 - $15.76 $224,098 - $358,193
-22,728 Reduced 0.99%
2,276,816 $27.2 Million
Q2 2022

Aug 12, 2022

BUY
$7.43 - $13.0 $1.82 Million - $3.18 Million
244,320 Added 11.89%
2,299,544 $29 Million
Q1 2022

May 12, 2022

BUY
$7.73 - $17.99 $63,300 - $147,320
8,189 Added 0.4%
2,055,224 $23.1 Million
Q4 2021

Feb 10, 2022

BUY
$16.5 - $25.48 $2.85 Million - $4.4 Million
172,674 Added 9.21%
2,047,035 $36.3 Million
Q3 2021

Nov 09, 2021

BUY
$17.81 - $24.87 $10.7 Million - $14.9 Million
600,832 Added 47.18%
1,874,361 $43.1 Million
Q2 2021

Aug 11, 2021

BUY
$22.19 - $31.55 $28.3 Million - $40.2 Million
1,273,529 New
1,273,529 $29.6 Million

Others Institutions Holding KNTE

About Kinnate Biopharma Inc.


  • Ticker KNTE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,145,600
  • Description
  • Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...
More about KNTE
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.